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Abstract 
The present study investigates a new family of bioactive glass nanoparticles with and 
without Sr doping focusing on the influence of the nanoparticles on human bone marrow 
stromal cells (hBMSCs) in vitro. The bioactive glass nanoparticles were fabricated by 
flame spray synthesis and a particle diameter of 30 to 35 nm was achieved. Glass 
nanoparticles were undoped (BG 13-93-0Sr) or doped with 5 wt.-% strontium (Sr) (BG 
13-93-5Sr) and used at concentrations of 10 µg/cm² and 100 µg/cm² (particles per 
culture plate area), respectively. Cells were cultured for 14 days after which the samples 
were analysed regarding metabolic activity and expression of various bone-specific 
genes. Cell growth and morphology indicated the high cytocompatibility of the 
nanoparticulate bioactive glass. The presence of the nanoparticles enhanced cell 
growth compared to the plain polystyrene control group. At a concentration of 100 
µg/cm², Sr-doped particles led to significantly enhanced gene expression of osteocalcin, 
collagen type 1 and vascular endothelial growth factor (VEGF). Thus Sr-doped 
nanoparticles showing a dose-dependent increase of osteogenic differentiation in 
hBMSCs are a promising biomaterial for bone regeneration purposes. 
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1. Introduction 
Bioactive glasses are widely used in the field of regenerative medicine due to their high 
bone bonding ability and their osteogenic potential (Hench and Polak 2002; Hoppe et al. 
2011). Ionic dissolution products released from bioactive glasses are known to stimulate 
several osteogenesis related genes (Hench 1998; Hoppe et al. 2011). Recently, novel 
approaches have been proposed in order to enhance the biocompatibility of bioactive 
glasses by adding bioactive metal ions to the glass network (Hoppe et al. 2011). Among 
many therapeutically active metals and inorganic ions, strontium (Sr) ions are known to 
have beneficial effects on bone cells and in vivo bone formation, the latter make them 
highly attractive agents for bone tissue engineering applications (Marie et al. 2001). 
Dissolution products from bioactive glasses doped with Sr have been shown to enhance 
osteogenic differentiation of human osteosarcoma cells (SaOS-2) and also to reduce 
osteoclast activity, hence, affecting bone turn over (Gentleman et al. 2010a).  
There is recent interest in investigating bioactive glass nanoparticles for bone 
regeneration due to their potential higher biological reactivity compared with 
conventional (µm- sized) particles  (Misra et al. 2008). Indeed nanoscaled bioactive 
glass particles have been shown to offer several advantages over micron sized 
particles, such as improved mechanical properties when used as filler materials in 
biocomposites (Boccaccini et al. 2010) or enhanced in vitro bioactivity (Misra et al. 
2008, Mackovic et al. 2012). Nanoparticulate bioactive glasses with a chemical structure 
that is similar to Hench’s 45S5 composition (Hench 1998) also display antibacterial 
properties and have potential for dentin remineralisation when applied to demineralised 
dentin matrix (Curtis et al. 2010; Vollenweider et al. 2007; Waltimo et al. 2007). Labbaf 
et al investigated sub-micron bioactive glass particles of composition 85 mol% SiO2 and 
15 mol% CaO, synthesised by the sol-gel process, confirming the non-toxicity of the 
sub-micron bioactive glass particles (Labbaf et al. 2011). It is thus of high interest to 
develop and investigate bioactive glass nanoparticles with different chemical 
composition. 
Flame spray synthesis, a scalable and cost efficient process to produce inorganic 
nanoparticles (Stark and Pratsinis, 2002, Teoh et al. 2010), was used in the present 
work for the first time to synthesize a new family of glass nanoparticles containing 7 
different components (SiO2, Na2O, P2O5, K2O, MgO, CaO and SrO). To the authors’ 
knowledge, there is no other technique that allows for synthesizing this kind of 
multicomponent nanoparticulate bioactive glass. Furthermore, this method guarantees 
narrow particle size distribution in addition to the low risk of product contamination 
(Brunner et al., 2006, Teoh et al., 2010). 
The aim of this study was thus to assess the osteogenic potential of a new family of 
bioactive glass nanoparticles containing Sr and to unveil possible stimulating effects of 
Sr ions on human bone marrow stromal cells (hBMSCs). Detailed gene expression 
profile of these cells will be used to determine any specific effects of Sr on osteogenic 
differentiation.  
 
2. Materials and Methods 
2.1 Material preparation and characterisation 
The nanoparticulate glasses were produced via a one step and dry synthesis method in 
a flame aerosol reactor described in detail by Brunner et al (Brunner et al. 2006). In 
brief, the corresponding metal precursors of Si (hexamethyldisiloxane, ABCR), Na 
(sodium hydroxide dissolved in 2-ethylhexanoic acid, Sigma Aldrich), P 
(tributylphosphate, Acros Organics), K (potassium bicarbonate dissolved in 2-
ethylhexanoic acid, Sigma Aldrich), Mg (magnesium oxide dissolved in 2-ethylhexanoic 
acid, Sigma Aldrich), Ca (calcium hydroxide dissolved in 2-ethylhexanoic acid, Sigma 
Aldrich) and Sr (strontium acetate dissolved in 2-ethylhexanoic acid, Sigma Aldrich) 
were mixed according to the final glass composition, as shown in Table 1, and diluted 
with xylene (technical grade). The solution was fed (5 ml/min) through a nozzle, 
dispersed by oxygen (5 l/min) and ignited with a preflame (methane/oxygen 1.13/2.4 
l/min). Particles formed during burning of the precursor were collected on a fibre filter 
mounted above the flame (40 cm). Collected particles were sieved (150 µm) and 
characterised subsequently.  
The specific surface area (SSA) of the nanoparticles was measured using the Brunauer-
Emmet-Teller (BET) method at 77 K on a Tristar instrument (Micromeritics, Norcross, 
GA, USA). Particle shape was determined with transmission electron microscopy (TEM) 
on a Tecnai F30 ST (FEI, FEG, 300 kV). X-ray diffraction (XRD) patterns were recorded 
on a X’Pert PRO-MPD diffractometer (Cu-Kα radiation, X’Celerator linear detector 
system, PANalytical, Netherlands) with a step size of 0.033°. 
For cell culture, bioactive glass nanoparticles were sterilised by dry heat at 180°C for 2 
h in a furnace. Afterwards the particles were dispersed in an ultrasonic bath (Sonorex 
RK102M; f=50-60Hz, Bandelin electronic, Berlin, Germany) in serum-free medium for 
30 minutes. Fetal bovine serum (FBS) was added prior to cell contact.  
 
2.2 Cell culture 
The hBMSCs were purchased from PromoCell (hMSC-BM, Catalogue number C-12975, 
PromoCell Heidelberg, Germany). Cells were cultured in flasks (COSTAR, Cambridge, 
USA) in an incubator (at 37 ºC and 5% CO2) and used at passage 5. The culture 
medium was used as DMEM/Ham’s F-12 (1:1) with 10% FBS, 1% penicillin-
streptomycin and 2 mg/l L-glutamine (all from Biochrom AG, Berlin, Germany). The 
medium was changed twice a week. At 80-90% confluency level cells were trypsinised 
(Trypsin EDTA, PAA, Pasching, Austria) and cultured further. After cell expansion, cells 
of passage 6 were used for the experiment. Cell morphology, growth and viability were 
observed over time by light microscopy (Leica DM IL, Leica, Wetzlar, Germany).  
2.3 Experimental design 
Five different groups were evaluated in this study. For the control group, hBMSCs were 
cultured on plain tissue culture polystyrene (well plates without glass particles). In 
addition, nanoparticulate glass without Sr (BG 13-93-0Sr) and Sr-doped nanoparticulate 
glass (BG 13-93-5Sr) were used each in two different concentrations, 10 µg/cm² and 
100 µg/cm² (particles per culture plate area). For light microscopic observations of 
cell culture an additional concentration of 1 µg/ml of each bioactive glass 
was included. Medium containing dispersed nanoparticulate glass was added and 50 
000 hBMSCs/well were seeded in 6-well plates (Cellstar®, Greiner Bio-One, 
Frickenhausen, Germany). The initial concentration of nanoparticles was each 2.4 µg/ml 
(in groups with 10 µg/cm²) and 24 µg/ml (in groups with 100 µg/cm²) in 4 ml of total cell 
culture medium. Only the upper half of medium was changed twice a week to ensure 
glass nanoparticles remaining at the bottom of the wells.  
2.4 ICP-MS analysis 
To measure Sr ions in the cell culture media and to detect differences in Sr-release 
between the experimental groups, the media were collected, pooled (6 independent 
samples) and used for analysis. Sr levels were quantified by inductively coupled 
plasma-mass spectroscopy (ICP-MS, Varian, Darmstadt, Germany) against standard 
solutions of 50 and 100 µg/l according to manufacturer’s instructions.   
2.5 Cell metabolic activity 
Metabolic activity of hBMSCs was analysed by AlamarBlue assay (Biosource Int., 
Camarillo, CA USA) after 14 days. The medium was aspirated and 1.5 ml of culture 
medium containing 10% AlamarBlue was added. After incubation for 3 hours at 37°C, 
absorbance was measured using a plate reader (SPECTRAmax 190, Molecular 
Devices, Sunnyvale, CA USA) at 570 nm and 600 nm. The percentage of AlamarBlue 
reduction was calculated according to manufacturer’s recommendations.  
2.6 Molecular analysis 
Cells for RNA isolation were detached (2 wells/sample) in triplicate with 1 ml of TRIzol 
Reagent (Invitrogen, Carlsbad, CA, US) and vortexed with 200 µl of Chloroform (Sigma-
Aldrich, Steinheim, Germany). Total RNA was isolated using RNeasy Mini Kit (Qiagen, 
Hilden, Germany) according to manufacturer’s instructions. RNA (1 mg) from each 
sample was reverse transcribed into complementary DNA using QuantiTect Reverse 
Transcription Kit (Qiagen, Hilden, Germany) according to manufacturer’s 
recommendations.  
Real-time reverse transcription polymerase chain reaction (RT-PCR) was performed 
with selected primer sequences as shown in Table 2. The expression of 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), osteocalcin, collagen type 1, 
vascular endothelial growth factor (VEGF) and Runt-related transcription factor 2 
(Runx2) was quantified using QuantiTect SYBR Green PCR Kit (iQ SYBR green, Bio-
Rad Laboratories, Hercules, CA USA). GAPDH was used as reference. Results were 
calculated using relative quantification (ΔΔCt method) compared to the control group. 
Every sample was analysed in duplicate. Results are expressed as fold changes of the 
expression of each gene in relation to the control group at each time point.  
2.7 Statistical analysis 
Results are given as mean ± standard error of the mean (SEM). A one-way analysis of 
variance (ANOVA) and Bonferroni’s multiple comparison posthoc test was used to 
compare various groups. P-values < 0.05 are considered as statistically significant. 
 
3. Results and discussion 
3.1 Electron microscopy 
TEM images revealed nanometric spherical particles that showed interconnectivity 
between the spheres whilst having an XRD-amorphous nature (Figure 1 and 
supplementary data). This behaviour is regularly observed for bioactive glass particles 
in the nanometric size range even if more oxides were present than for the classical 
45S5 Bioglass® (Mohn et al. 2010). The SSA of all as-prepared particles was in the 
same range and confirmed the nanoscale of the particles (Table 1). 
3.2 Strontium dissolution assay 
Amounts of Sr ions in cell culture media were detected by ICP-MS analysis after 2 
weeks (Figure 2A). There was a basal amount of Sr (22 µg/l) in the control culture 
medium attributable to the serum. The same basal Sr level was found in the media of 
groups with Sr-free (BG 13-93-0Sr) bioactive glass. The highest amount of Sr was 
measured in the culture medium of the group containing 100 µg/cm² Sr-doped 
nanoparticulate glass (BG 13-93-5Sr). Of course, it was impossible to avoid some Sr 
ions getting lost by media changes over time. However, ICP analyses confirmed that Sr-
doped nanoparticles led to critical Sr levels in culture medium even after 2 weeks. Sr 
levels were 77.01 µg/l for samples with 10 µg/cm² Sr-doped particles and 480.30 µg/l in 
samples with 100 µg/cm² Sr-doped particles. A continuous effect of Sr on the cells can 
consequently be assumed. Lao et al investigated the release of Sr in DMEM using Sr-
doped mesoporous bioactive glass discs and particles (0, 1, 5 wt.-%) (Lao et al. 2008). 
After 10 days of interaction, the measured Sr concentrations were similar to 
concentrations in plasma of animals treated with Sr-based drugs showing anti-
osteoporotic effects (Dahl et al. 2001). Additionally, influences of Sr on bioactive 
glasses were found, such as induced and accelerated formation of surface bone-like 
apatite layers and reduced dissolution of the mesoporous glasses (Lao et al. 2008). 
Recently, Wu et al used periodontal ligament cells (PDLCs) to investigate the effect of 
Sr-incorporation in mesoporous bioactive glass scaffolds and showed increased ALP 
activity and cementogenic gene expression (Wu et al. 2012). In vivo studies with 
different bioactive glasses containing Sr have shown biocompatibility, osteoconductivity 
and bone formation, offering advantages also in osteoporotic animals (Boyd et al. 2009; 
Gorustovich et al. 2010b). These observations are indicative that the currently used 
materials encourage cell adhesion and provide a certain degree of bone healing 
capacity even without exhibiting a nanostructure. In the present study, it was possible to 
optimise potential bone formation properties by combining the advantages of bioactive 
glass and Sr-release with the nanoscale dimension of the particles used. Further 
experiments with Sr-doped nanoparticles to investigate the influence of Sr on bioactivity 
as well as Sr-release kinetics and to develop controlled Sr-releasing systems are thus 
justified following the present results.   
 
3.3 Cell proliferation and metabolic activity 
Cell morphology and viability were observed in every group by light microscopy over 
time. After 14 days of culture the common spindle-like morphology of viable hBMSCs 
was observed as shown in Figure 3. At this time an adequate number of cells were 
achieved in the well plate. There were no indications of cytotoxic effects of the material 
or infections. Due to the low magnification of the lightmicroscopic picture, nanoparticles 
are not visible in Figure 3. Nevertheless, evaluation of the effects of nanoparticles show 
that the cell growth is increased by a higher concentration of nanoparticles. The 
presence of Sr seems to have no appreciable influence on cell morphology and 
interaction of hBMSCs.  
After 14 days, AlamarBlue analysis confirmed the microscopic observations regarding 
cell proliferation. Metabolic activity of hBMSCs was significantly enhanced in both 
groups containing 100 µg/cm² nanoparticulate glass compared to the control group 
(Figure 2B). In the current experiment, no influence of Sr on metabolic activity of 
hBMSCs could be detected (no statistical significance between BG 13-93-0Sr and BG 
13-93-5Sr groups).  
While plenty is known about the effect of growth factors and cytokines on hBMSCs, 
there still is a lack of information regarding physical and chemical extracellular 
conditions regulating proliferation and differentiation of bone cells. Nanostructures 
imitate the extracellular matrix of natural bone. These structures are supposed to 
improve bone cell adhesion due to high porosity as well as high surface area-to-volume-
ratio (Lim et al. 2011). Besides, ionic dissolution products of bioactive glasses are 
known to stimulate the growth of human osteoblasts (Sun et al. 2007). In this study, 
both nanoparticulate glasses were proved to be cytocompatible and non-toxic. Indeed, 
metabolic activity of hBMSCs could be significantly enhanced by merging the 
advantages of bioactive glasses and nanoscaled particles. Consistent with our above-
mentioned findings, it has been described previously that Sr-incorporation in bioactive 
glass has no influence on osteoblastic cell growth at an early culture time (after 2 and 4 
days of cultivation) (Isaac et al. 2011). Furthermore, Sila-Asna et al reported that Sr-
containing cell culture medium does not affect the proliferation of hBMSCs up to 18 
days and enhances proliferation only after 21 days of interaction (Sila-Asna et al. 2007).  
3.4 Quantitative real-time RT-PCR 
To investigate the osteogenic differentiation of hBMSCs, bone specific gene expression 
was detected after 14 days. Cells grown on polystyrene (without nanoparticulate 
bioactive glass) served as control. The expression of osteocalcin and collagen type 1 
was significantly up-regulated in cells cultured in presence of 100 µg/cm² Sr-doped 
nanoparticles compared to all other groups (Figure 4). These results show a strong 
enhancement of bone-specific genes due to Sr-containing bioactive glass without any 
osteoinductive medium supplements. 
The two main types of proteins in the extracellular matrix of bone are collagens (mainly 
collagen type 1) and the noncollagenous proteins, for example osteocalcin. Osteocalcin 
is known as the most specific protein for osteogenic matrix maturation. It is found in 
post-mitotic mature osteoblasts (Aubin et al. 1995). Moreover, Runx2 is indicative of 
osteoblast differentiation, as it is a key transcription factor for up-regulation of 
osteocalcin, collagen type 1 and other bone-specific genes. The extent of collagen type 
1 expression and Runx2 expression in the samples correlated well with the osteocalcin-
expression (Figure 4). VEGF is known to enhance angiogenic properties in various cell 
types including induced expression of certain microRNAs that enhance CD34+ stem cell 
function (Alaiti et al. 2012). This analysis shows that not only osteogenic but also the 
angiogenic marker VEGF is up-regulated by Sr-doped nanoparticles providing attractive 
properties for bone regeneration. Moreover, cells cultured in presence of both types of 
nanoparticulate glasses showed slightly enhanced bone-specific gene expression 
patterns compared to the control group. Nevertheless, this finding is not statistically 
significant in the current experimental setting. This result may be due to the limited 
sample size and the fixed time of analysis. Bioactive glasses have attracted much 
attention in bone tissue engineering because of their osteogenic properties (Gentleman 
et al. 2010b; Hoppe et al. 2011; Sun et al. 2007). The released ionic dissolution 
products are capable of enhancing proliferation and differentiation of bone cells and 
inducing angiogenesis (Gorustovich et al. 2010a; Hoppe et al. 2011; Xynos et al. 2000).  
It has already been shown that Sr promotes osteogenic differentiation of bone cells 
through different signalling pathways (Peng et al. 2009; Yang et al. 2011). Briefly, Sr 
enhances bone formation by inhibition of osteoclasts and stimulation of osteoblasts 
(Marie et al. 2001). Isaac et al demonstrated enhanced osteogenic properties due to Sr-
doping of bioactive glasses (Isaac et al. 2011). Moreover, hydroxyapatite (HAP) 
nanoparticles that were Sr-doped resulted in higher osteoconductive and osteoinductive 
behaviour in comparison to Sr-free particles, as reported in a very recent study (Hao et 
al. 2012). 
Based on our observations, the present nanoparticles possess high biological activity 
and osteogenic properties which are attributed to the benefit of both the Sr-doping and 
nanostructured surface. A dose-dependent stimulating effect of Sr-doped 
nanoparticulate glass on osteogenic cells can be assumed. In addition to optimisation of 
biomaterial composition and properties, adequate cell sources are required for 
successful bone regeneration. hBMSCs are commonly used in bone tissue engineering 
showing well-known characteristics of stem cells such as self-renewal, multipotency and 
high potential for ex vivo expansion. Especially in the rapid developing field of “nano-
regenerative medicine”, hBMSCs seem to be a favourable cell source (Arora et al. 
2012).  
Regarding standard in vivo models for bone tissue engineering purposes, Sr-doped 
bioactive glass nanoparticles could be applied in many different ways. For instance, 
particles could be used as add-on to cell suspensions or as a surface coating on three-
dimensional bone substitutes. So the bioactive glass nanoparticles used in this study 
provide high potential to become a therapeutic option for bone tissue engineering 
applications and should be analysed in standard in vivo models.  
 
4. Conclusions 
The present study introduces a novel Sr-doped nanostructured bioactive glass with 
primary particle diameters in the range of 30-35 nm. This nanoscale biomaterial might 
promote osteogenic and angiogenic properties of hBMSCs. Cell metabolic activity was 
found to be independent of Sr, but increased in presence of nanoparticulate glass. 
hBMSCs that were cultured in presence of the Sr-doped nanoparticles developed a 
significant upregulation of osteocalcin, collagen type 1 and VEGF. These findings 
indicate that the currently described Sr-doped nanostructured glass combines the Sr-
induced osteogenic stimulation with the advantageous properties of nanostructures and 
bioactive glasses. Our observations provide the basis for further studies with regard to 
Sr-delivering nanostructured glasses for bone tissue engineering applications.  
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Table 1. Compositions of bioactive glass nanoparticels used. 
 SiO2 
[wt%] 
Na2O 
[wt%] 
P2O5 
[wt%] 
K2O 
[wt%] 
MgO 
[wt%] 
CaO 
[wt%] 
SrO 
[wt%] 
SSAa 
[m2/g] 
dBETb 
[nm] 
BG 13-93-0Sr 53 6 4 12 5 20 0 69 34 
BG 13-93-5Sr 53 6 4 12 5 15 5 74 31 
a Error ± 5% 
b BET equivalent primary particle diameter, calculated by 6 / SSA ρ. For ρ the mixed density was 
calculated according to the wt%. 
 
Table 2. Primer design 
Gene Forward primer Reverse primer 
GAPDH 5’ ATCAAGTGGGGCGATGCTGG 3’ 5’ CCATGACGAACATGGGGGCA 3’ 
OC 5’ ACCATGAGAGCCCTCACACTCCT 3’ 5’ GTCTCTTCACTACCTCGCTGCC 3’ 
Runx2 5’ TTACCCCTCCTACCTGAGCCAG 3’ 5’ TTCTGAAGCACCTGAAATGCGC 3’ 
Col-1  5’ TGTTCAGCTTTGTGGACCTCCG 3’ 5’ CTGAGGCCGTTCTGTACGCA 3’ 
VEGF 5’ AGGAGGAGGGCAGAATCATCA 3’ 5’ CTCGATTGGATGGCAGTAGCT 3’ 
 
 
 
 
Figure captions: 
 
Figure 1. TEM image of the 13-93-5Sr bioactive glass nanoparticles. 
 
Figure 2. A) Inductively coupled plasma (ICP) analysis of Sr (µg/l) in pooled cell culture medium (of 6 
independent samples/group) after 2 weeks. B) Cell metabolism measured by AlamarBlue assay after 2 
weeks of cell culture. Results are given as mean ± SEM. *p < 0.05.  
 
Figure 3. Light microscopy of hBMSCs after 14 days of culture showing increased cell growth in groups 
with a higher concentration of bioactive glass nanoparticles. 
 
Figure 4. Quantitative real time RT-PCR analyses for osteocalcin (A), collagen type 1 (B), VEGF (C) and 
Runx2 (D) (expressed as gene expression related to control group, ΔΔCT-method). Shown are mean ± 
SEM. *p < 0.05. 
 
 
Supplementary data. XRD spectra of BG13-93-0Sr and Sr-containing BG13-93 with different Sr content  
 
 





